
Novel pyrimidoazepine analogs as serotonin 5-HT2A and 5-HT2C receptor ligands for the treatment of obesity
Keywords: 5-HT2A antagonist; 5-HT2C antagonist; Obesity; Pyrimidoazepine; Serotonin receptor ligands